Profil
Nabil A.
Abadir is currently the Global Chief Medical Officer & Senior VP at Amarin Corp.
Plc.
Prior to this role, he served as the Executive VP-Medical & Scientific Affairs at Clementia Pharmaceuticals, Inc.
Aktive Positionen von Nabil A. Abadir
| Unternehmen | Position | Beginn |
|---|---|---|
| AMARIN CORPORATION PLC | Chief Tech/Sci/R&D Officer | 01.04.2022 |
Ehemalige bekannte Positionen von Nabil A. Abadir
| Unternehmen | Position | Ende |
|---|---|---|
| CLEMENTIA PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada. | Health Technology |
